Allergy Therapeutics Plc is a biotechnology company, which engages in the Research and Development of allergy treatments. The company was founded by Keith Iain Carter in 1998 and is headquartered in Worthing, the United Kingdom.
The current price of HHU is 0.06 EUR — it hasn't changed in the past 24 hours. Watch ALLERGY THERAPEUTICS PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ALLERGY THERAPEUTICS PLC stocks are traded under the ticker HHU.
HHU stock has fallen by 13.67% compared to the previous week, the month change is a 39.53% rise, over the last year ALLERGY THERAPEUTICS PLC has showed a 87.50% increase.
HHU reached its all-time high on Jun 11, 2024 with the price of 0.08 EUR, and its all-time low was 0.03 EUR and was reached on May 13, 2024. View more price dynamics on HHU chart. See other stocks reaching their highest and lowest prices.
HHU stock is 15.83% volatile and has beta coefficient of 1.49. Track ALLERGY THERAPEUTICS PLC stock price on the chart and check out the list of the most volatile stocks — is ALLERGY THERAPEUTICS PLC there?
Today ALLERGY THERAPEUTICS PLC has the market capitalization of 295.93 M, it has increased by 0.89% over the last week.
ALLERGY THERAPEUTICS PLC is going to release the next earnings report on Sep 25, 2024. Keep track of upcoming events with our Earnings Calendar.
ALLERGY THERAPEUTICS PLC revenue for the last half-year amounts to 38.72 M EUR, despite the estimated figure of 38.75 M EUR. In the next half-year revenue is expected to reach 33.11 M EUR.
HHU net income for the last half-year is −18.05 M EUR, while the previous report showed −40.22 M EUR of net income which accounts for 55.12% change. Track more ALLERGY THERAPEUTICS PLC financial stats to get the full picture.
No, HHU doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 21, 2024, the company has 612.00 employees. See our rating of the largest employees — is ALLERGY THERAPEUTICS PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALLERGY THERAPEUTICS PLC EBITDA is −41.45 M EUR, and current EBITDA margin is −51.40%. See more stats in ALLERGY THERAPEUTICS PLC financial statements.
Like other stocks, HHU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALLERGY THERAPEUTICS PLC stock right from TradingView charts — choose your broker and connect to your account.